T/NK-cell lymphomas/leukemias: Shedding new light on these rare diseases

Cancer Control

Volumn 14, Issue 2, 2007, Pages 96-97

  Sokol, Lubomir ^a   Glass, L Frank ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; CD2 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD52 ANTIGEN; DENILEUKIN DIFTITOX; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 2 RECEPTOR ALPHA; MOLECULAR MARKER; RETINOID; REXINOID; UNCLASSIFIED DRUG; VORINOSTAT;

ANAPLASTIC CARCINOMA; B CELL LEUKEMIA; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; EDITORIAL; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPHENOTYPING; LARGE GRANULAR LYMPHOCYTE; LEUKEMIA; LYMPHOMA; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; MYCOSIS FUNGOIDES; NATURAL KILLER CELL; NATURAL KILLER CELL LEUKEMIA; NATURAL KILLER CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; RARE DISEASE; SEZARY SYNDROME; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 34047129688     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480701400201     Document Type: Editorial

References (2)

1. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785. Epub 2005 Feb 3.